Global Healing: Literature, Advocacy, Care, Karen Laura Thornber analyzes how narratives from diverse communities globally engage with a broad variety of diseases and other serious health conditions and advocate for empathic, compassionate, and respectful care that facilitates healing and enables wellbeing.
The three parts of this book discuss writings from Africa, the Americas, Asia, Europe, the Middle East, and Oceania that implore societies to shatter the devastating social stigmas which prevent billions from accessing effective care; to increase the availability of quality person-focused healthcare; and to prioritize partnerships that facilitate healing and enable wellbeing for both patients and loved ones.
Global Healing remaps the contours of comparative literature, world literature, the medical humanities, and the health humanities.
The meanings of disease have undergone such drastic changes with the introduction of modern Western medicine into China during the last two hundred years that new discourses have been invented to theorize illness, redefine health, and reconstruct classes and genders. As a consequence, medical literature is rewritten with histories of hygiene, studies of psychopathology, and stories of cancer, disabilities and pandemics. This edited volume includes studies of discourses about both bodily and psychiatric illness in modern China, bringing together ground-breaking scholarships that reconfigure the fields of history, literature, film, psychology, anthropology, and gender studies by tracing the pathological path of the “Sick Man of East Asia” through the nineteenth and twentieth centuries into the new millennium.
How do doctors decide whether their drugs, or other treatments, actually work? In practice this can be fiendishly difficult. Nowadays the gold standard is the randomised controlled trial (RCT). But the RCT is a recent invention, and the story of how it came to dominate therapeutic evaluation from the latter half of the twentieth century involves acrimony, confrontation, and manipulation of the powerful rhetoric of ‘control’.
Control and the Therapeutic Trial examines the development of the RCT from the eclectic collection of methodologies available to practitioners in the early-twentieth century. In particular, it explores the British Medical Research Council’s (MRC) exploitation of the term ‘controlled’ to help establish its own ‘controlled trials’ as the gold standard for therapeutic evaluation, and, ultimately, the MRC itself as the proper authority to adjudicate on therapeutic efficacy. This rhetorical power still clings, and is exploited today.
Control and the Therapeutic Trial will be of interest not only to historians of twentieth-century medicine and practising clinicians who take therapeutic decisions, but to anyone who seeks a broader insight into the forces that shaped, and control, the modern controlled trial.